Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02627495 · ClinicalTrials.gov registry record

Predicting Pain Response to Transcranial Direct Current Stimulation for Phantom Limb Pain in Limb Amputees

A clinical trial of Phantom Limb Pain, sponsored by Spaulding Rehabilitation Hospital.

Completed
Registry status
9
Enrollment target
1
Study location

NCT02627495: Completed study of Phantom Limb Pain, sponsored by Spaulding Rehabilitation Hospital.

NCT02627495 is a study of Phantom Limb Pain that has completed, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 9 participants, below the 122-participant average among 12 other Phantom Limb Pain trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02627495, a study of Phantom Limb Pain, has completed, sponsored by Spaulding Rehabilitation Hospital.

COMPLETED
Registry status
9 participants
Enrollment target
1
Study location

Study Summary

This study explores the effects transcranial Direct Current Stimulation (tDCS, Soterix ©) on Phantom Limb Pain for patients experiencing chronic phantom limb pain in open-label study design.

Primary Outcome

The VAS is a common assessment used which asks subjects to self-reportedly measure their pain on a visual scale (i.e., unbearable to none). We will use a VAS to determine subjects' pain scores. Subjects will rate their pain from 0 - indicating no pain at all, to 10 - indicating the worst pain felt. This scale is also colored, from green (at 0) to red (at 10), as a visual indicator of pain.

Conditions Studied

Phantom Limb Pain

Interventions

  • DEVICE transcranial Direct Current Stimulation (tDCS): (Soterix ©)

Study Locations (1)

Massachusetts

  • Spaulding Rehabilitation Hospital - Boston

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2015-12-01
Est. Completion 2021-03-09
Spaulding Rehabilitation Hospital

101 total trials

What the finished NCT02627495 record still lists

NCT02627495 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 122-participant average among 12 other Phantom Limb Pain trials with a reported enrollment target (93% lower).

The record links to 1 condition, with Phantom Limb Pain appearing as the primary indexed condition, and to 1 intervention - of which transcranial Direct Current Stimulation (tDCS): (Soterix ©) is the first listed.

NCT02627495 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02627495 about?

NCT02627495 is a clinical study titled "Predicting Pain Response to Transcranial Direct Current Stimulation for Phantom Limb Pain in Limb Amputees". This study explores the effects transcranial Direct Current Stimulation (tDCS, Soterix ©) on Phantom Limb Pain for patients experiencing chronic phantom limb pain in open-label study design.

What is the current status of trial NCT02627495?

This trial is currently completed. The enrollment target is 9 participants. The study started on 2015-12-01. Estimated completion is 2021-03-09.

What conditions does trial NCT02627495 study?

This clinical trial studies the following conditions: Phantom Limb Pain.

What interventions are being tested in trial NCT02627495?

The interventions under investigation include: transcranial Direct Current Stimulation (tDCS): (Soterix ©) (DEVICE).

Who is sponsoring clinical trial NCT02627495?

This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02627495 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Phantom Limb Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02627495's enrollment target sits among peer trials

9 11th of 12 higher than 2 of 12 other Phantom Limb Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phantom Limb Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT02627495, the US trial registry maintained by the National Library of Medicine. NCT02627495 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.